Emergent BioSolutions Inc. — Director's Dealing 2024

Nov 13, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2024-11-11

Reporting Person: White Marvin L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-11-11	Common Stock	S	14287	$11.97	Disposed	54092	Direct

Footnotes

F1: On November 11, 2024, Mr. White sold an aggregate of 14,287 shares of Emergent BioSolutions Inc. common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $11.84 - $12.11. The Company maintains a record of the transactions and copies will be provided upon request.